Axon (AXON) Was the S&P’s Biggest Loser — and it’s Not Entirely the Business’s Fault

On September 1, 2026, Axon Enterprise, Inc. (NASDAQ:AXON) fell 8.52% to roughly $518.30, marking the steepest daily drop in the S&P 500 and extending its decline to roughly 35% below its 52-week high of $792. The stock trades at roughly the high-50s multiple of forward earnings, leaving its valuation particularly sensitive to higher discount rates. As Treasury yields climbed sharply amid a broader global bond selloff, the company absorbed severe valuation compression despite delivering a strong quarterly report weeks earlier.

The Business Kept Compounding

Axon’s second-quarter earnings, reported August 5, reflected a strong operational performance. Revenue rose 35% to $904 million, annual recurring revenue expanded 39% to $1.6 billion, net revenue retention reached 126%, and contracted backlog grew 41% to $15.1 billion. Management also lifted full-year revenue growth guidance to the range of 32% to 34%, marking ten consecutive quarters of growth exceeding 30%. Barclays, Needham, and William Blair all stayed bullish on the stock. The Street consensus still implies approximately 30% upside. The operating results therefore suggest that valuation compression, rather than a deterioration in headline growth, has been a major driver of the de-rating.

But the Cracks Are Real, Not Just Macro

Few internal factors also contributed to the pullback. Adjusted gross margin of 62.9% benefited from one-time tariff refunds that are now expiring. Meanwhile, the rising memory component costs are expected to pressure Q3 profitability. Additionally, free cash flow was near zero, recording a $1 million outflow, even against a $450 million full-year target. A growing backlash against automated license-plate readers adds regulatory complications which the company’s multiple does not discount.

A Duration Trade Dressed as a Stock Pick

Institutional data reflects this caution. Insider Monkey tracked 53 hedge funds holding AXON in the second quarter of 2026, down from 59 in the previous quarter. Short interest stood at near 5% of the float.

Bottom Line

Axon Enterprise, Inc. continues to be a steady grower backed by a $15.1 billion backlog. This makes the valuation pullbacks attractive for long-term investors. However, it is a high multiple, meaning it doesn’t have any cushion for component-cost pressures or fading tariff credits when bond yields stay elevated. Accumulate only if your risk tolerance can handle additional valuation compression. And watch whether gross margins stabilize in the next quarters as cost pressures peak.

READ NEXT: Spyre (SYRE) Fell 13% on Its Weakest Program. Its Best One Just Worked and The PayPal (PYPL) Buyout Is No More. Now Investors Have to Decide if the Business Is Worth It.

Follow Insider Monkey on Google News.